Tg在分化型甲状腺癌中的临床价值探讨
The Clinical Value of Tg in Differentiated Thyroid Carcinoma
DOI: 10.12677/ACM.2023.1361455, PDF,   
作者: 陈博文：西安医学院研究生院，陕西 西安；空军军医大学第一附属医院核医学科，陕西 西安；马温惠, 杨治平, 汪 静*：空军军医大学第一附属医院核医学科，陕西 西安
关键词: 甲状腺球蛋白；甲状腺癌；综述文献；Thyroglobulin； Thyroid Cancer； Literature Review
摘要: 甲状腺球蛋白(Thyroglobulin, Tg)在甲状腺癌的诊断、治疗和预后中有重要作用。研究Tg在分化型甲状腺癌(differentiated thyroid carcinoma, DTC)诊疗一体化中的关键作用，对是否需要放射性碘治疗、评估治疗效果和患者生存预后进行临床汇总。结合文献，同时与临床现状相结合整理总结出现有研究的进展与不足，进一步提出思考与展望。
Abstract: Thyroglobulin (Tg) plays an important role in the diagnosis, treatment and prognosis of thyroid cancer. To investigate the key role of Tg in the integration of diagnosis and treatment of differenti-ated thyroid carcinoma (DTC), and to summarize the need for radioiodine treatment, evaluation of treatment effect and survival prognosis of patients, combined with the literature, and combined with the clinical status, the research progress and shortcomings were summarized, and further thought and prospect were put forward.
文章引用：陈博文, 马温惠, 杨治平, 汪静. Tg在分化型甲状腺癌中的临床价值探讨[J]. 临床医学进展, 2023, 13(6): 10395-10402. https://doi.org/10.12677/ACM.2023.1361455

参考文献

[1] Coscia, F., et al. (2020) The Structure of Human Thyroglobulin. Nature, 578, 627-630. [Google Scholar] [CrossRef] [PubMed]
[2] 龙佩, 张雷, 何流, 等. 检测分化型甲状腺癌患者术前Tg.TgAh及TSH水平的临床分析[J]. 中国医学装备, 2017, 10(14): 97-100.
[3] Citterio, C.E., Targovnik, H.M. and Arvan, P. (2019) The Role of Thyroglobulin in Thyroid Hormonogenesis. Nature Reviews Endocrinology, 15, 323-338. [Google Scholar] [CrossRef] [PubMed]
[4] 张娜. 有关甲状腺球蛋白抗体与甲状腺乳头状癌131I治疗疗效关系的系列研究[D]: [硕士学位论文]. 青岛: 青岛大学, 2018.
[5] Szujo, S., Bajnok, L., Bodis, B., et al. (2021) The Prognostic Role of Postablative Non-Stimulated Thyroglobulin in Differentiated Thyroid Cancer. Cancers, 13, Arti-cle No. 310. [Google Scholar] [CrossRef] [PubMed]
[6] 徐淑英, 严春霞, 沈冬明. 抗甲状腺球蛋白抗体对妇女甲状腺乳头状癌发病的影响[J]. 中国肿瘤临床与康复, 2021, 28(1): 59-62.
[7] Zou, X., Gao, F., Wang, Z.Y., et al. (2020) A Three-microRNA Panel in Serum as Novel Biomarker for Papillary Thyroid Carcinoma Diagnosis. Chi-nese Medical Journal (England), 133, 2543-2551. [Google Scholar] [CrossRef] 
[8] Hillebrand, J.J., Siegelaar, S.E. and Heijboer, A.C. (2020) Falsely Decreased Thyroglobulin Levels in a Patient with Differentiated Thyroid Carcinoma. Clinica Chimica Acta; In-ternational Journal of Clinical Chemistry, 509, 217-219. [Google Scholar] [CrossRef] [PubMed]
[9] 史育红, 唐芳, 张波. 对比分析甲状腺球蛋白抗体对电化学发光法和免疫放射法测定甲状腺球蛋白的干扰[J]. 标记免疫分析与临床, 2020, 27(11): 1998-2002.
[10] Bílek, R., Dvořáková, M., Grimmichová, T., et al. (2020) Thyroglobulin and Thyroid Gland. Physiological Research, 69, S225-S236. [Google Scholar] [CrossRef] [PubMed]
[11] Bílek, R., Čeřovská, J. and Zamrazil, V. (2015) The Relationship between Iodine Intake and Serum Thyroglobulin in the General Population. Physiological Research, 64, 345-353. [Google Scholar] [CrossRef] [PubMed]
[12] 费扬帆, 马徐颖, 王亚平, 等. 血清Tg、TSH对分化型甲状腺癌的诊断价值[J]. 癌症进展, 2019, 17(15): 1786-1788+1816.
[13] 单凤玲, 陆汉魁. 甲状腺球蛋白实验研究进展与临床应用[J]. 中国普通外科杂志, 2017, 26(5): 648-654.
[14] 陈艳林. Tg对甲状腺自身免疫异常的DTC患者预后监测的价值[D]: [硕士学位论文]. 郑州: 郑州大学, 2013.
[15] Kim, H., Park, S.Y., Choe, J.H., et al. (2020) Preoperative Serum Thyroglobulin and Its Correlation with the Burden and Extent of Differentiated Thyroid Can-cer. Cancers, 12, Article No. 625. [Google Scholar] [CrossRef] [PubMed]
[16] Machens, A. and Dralle, H. (2010) Biomarker-Based Risk Stratification for Previously Untreated Medullary Thyroid Cancer. The Journal of Clinical Endo-crinology and Metabolism, 95, 2655-2663. [Google Scholar] [CrossRef] [PubMed]
[17] Patell, R., Mikhael, A., Tabet, M., et al. (2018) Assessing the Utility of Preoperative Serum Thyroglobulin in Differentiated Thyroid Cancer: A Retro-spective Cohort Study. Endocrine, 61, 506-510. [Google Scholar] [CrossRef] [PubMed]
[18] Oltmann, S.C., Leverson, G., Lin, S.H., et al. (2014) Markedly Elevated Thyroglobulin Levels in the Preoperative Thyroidectomy Patient Correlates with Metastatic Burden. The Journal of Surgical Research, 187, 1-5. [Google Scholar] [CrossRef] [PubMed]
[19] Li, S., Ren, C., Gong, Y., et al. (2022) The Role of Thyroglobulin in Preoperative and Postoperative Evaluation of Patients with Differentiated Thyroid Cancer. Frontiers in Endocrinology (Lausanne), 13, Article ID: 872527. [Google Scholar] [CrossRef] [PubMed]
[20] Petric, R., Perhavec, A., Gazic, B., et al. (2012) Preoperative Se-rum Thyroglobulin Concentration Is an Independent Predictive Factor of Malignancy in Follicular Neoplasms of the Thyroid Gland. Journal of Surgical Oncology, 105, 351-356. [Google Scholar] [CrossRef] [PubMed]
[21] McDow, A.D., Shumway, C.M., Pitt, S.C., et al. (2019) Utility of Early Postoperative Unstimulated Thyroglobulin in Influencing Decision Making in Patients with Papillary Thyroid Carcinoma. Annals of Surgical Oncology, 26, 4002-4007. [Google Scholar] [CrossRef] [PubMed]
[22] Jayasekara, J., Jonker, P., Lin, J.F., et al. (2020) Early Postoper-ative Stimulated Serum Thyroglobulin Quantifies Risk of Recurrence in Papillary Thyroid Cancer. Surgery, 167, 40-45. [Google Scholar] [CrossRef] [PubMed]
[23] Mazzaferri, E.L., Robbins, R.J., Spencer, C.A., et al. (2003) A Consensus Report of the Role of Serum Thyroglobulin as a Monitoring Method for Low-Risk Patients with Papillary Thyroid Carcinoma. The Journal of Clinical Endocrinology and Metabolism, 88, 1433-1441. [Google Scholar] [CrossRef] [PubMed]
[24] Hall, F.T., Beasley, N.J., Eski, S.J., et al. (2003) Predictive Value of Serum Thyroglobulin after Surgery for Thyroidcarcinoma. Laryngoscope, 113, 77-81. [Google Scholar] [CrossRef] [PubMed]
[25] Orlov, S., Salari, F., Kashat, L., et al. (2015) Post-Operative Stimulated Thyroglobulin and Neck Ultrasound as Personalized Criteria for Risk Stratification and Radi-oactive Iodine Selection in Low- and Intermediate-Risk Papillary Thyroid Cancer. Endocrine, 50, 130-137. [Google Scholar] [CrossRef] [PubMed]
[26] Xing, Z., Qiu, Y., Li, Z., et al. (2021) Predictors of Thyroglobulin in the Lymph Nodes Recurrence of Papillary Thyroid Carcinoma Undergoing Total Thyroidectomy. BMC Surgery, 21, Article No. 53. [Google Scholar] [CrossRef] [PubMed]
[27] Cho, J.S. and Kim, H.K. (1993) Thyroglobulin Level as a Predic-tive Factor of Tumoral Recurrence in Differentiated Thyroid Cancer. Journal of Nuclear Medicine, 32, 395-398.
[28] Webb, R.C., Howard, R.S., Stojadinovic, A., et al. (2012) The Utility of Serum Thyroglobulin Measure-ment at the Time of Remnant Ablation for Predicting Disease-Free Status in Patients with Differentiated Thyroid Cancer: A Meta-Analysis Involving 3947 Patients. The Journal of Clinical Endocrinology & Metabolism, 97, 2754-2763. [Google Scholar] [CrossRef] [PubMed]
[29] Lee, S.H., Roh, J.L., Gong, G., et al. (2019) Risk Factors for Recurrence after Treatment of N1b Papillary Thyroid Carcinoma. Annals of Surgery, 269, 966-971. [Google Scholar] [CrossRef] 
[30] Kim, S.J., Park, S.Y., Lee, Y.J., et al. (2014) Risk Factors for Recurrence after Therapeutic Lateral Neck Dissection for Primary Papillary Thyroid Cancer. Annals of Surgical On-cology, 21, 1884-1890. [Google Scholar] [CrossRef] [PubMed]
[31] Kendler, D.B., Vaisman, F., Corbo, R., et al. (2012) Preablation Stimulated Thyroglobulin Is a Good Predictor of Successful Ablation in Patients with Differentiated Thyroid Cancer. Clinical Nuclear Medicine, 37, 545-549. [Google Scholar] [CrossRef] 
[32] Stevic, I., Dembinski, T.C., Pathak, K.A., et al. (2015) Tran-sient Early Increase in Thyroglobulin Levels Post-Radioiodine Ablation in Patients with Differentiated Thyroid Cancer. Clinical Biochemistry, 48, 658-661. [Google Scholar] [CrossRef] [PubMed]
[33] Brassard, M., Borget, I., Edet-Sanson, A., et al. (2011) Long-Term Follow-Up of Patients with Papillary and Follicular Thyroid Cancer: A Prospective Study on 715 Patients. The Journal of Clinical Endocrinology and Metabolism, 96, 1352-1359. [Google Scholar] [CrossRef] [PubMed]
[34] Trimboli, P., Zilioli, V., Imperiali, M., et al. (2017) High-Sensitive Basal Serum Thyroglobulin 6 - 12 Months after Thyroid Ablation Is Strongly Associated with Early Response to Therapy and Event-Free Survival in Patients with Low-to-Intermediate Risk Differentiated Thyroid Carcinomas. European Journal of Endocrinology, 5, 497-504. [Google Scholar] [CrossRef] 
[35] Malandrino, P., Tumino, D. and Russo, M. (2019) Surveillance of Pa-tients with Differentiated Thyroid Cancer and Indeterminate Response: A Longitudinal Study on Basal Thyroglobulin Trend. Journal of Endocrinological Investigation, 42, 1223-1230. [Google Scholar] [CrossRef] [PubMed]
[36] Rosario, P.W., Mourão, G.F. and Calsolari, M.R. (2019) Defini-tion of the Response to Initial Therapy with Radioiodine in Patients with Differentiated Thyroid Carcinoma: Basal or Stimulated Thyroglobulin? Hormone and Metabolic Research, 51, 634-638. [Google Scholar] [CrossRef] [PubMed]
[37] Hu, H.Y., Liang, J., Zhang, T., et al. (2018) Suppressed Thyroglobulin Performs Better than Stimulated Thyroglobulin in Defining an Excellent Response in Patients with Differentiated Thyroid Cancer. Nuclear Medicine Communications, 39, 247-251. [Google Scholar] [CrossRef] 
[38] Xu, S., Huang, H., Zhang, X., et al. (2021) Predictive Value of Serum Thyroglobulin for Structural Recurrence Following Lobectomy for Papillary Thyroid Carcinoma. Thy-roid, 31, 1391-1399. [Google Scholar] [CrossRef] [PubMed]

为你推荐